Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer
Metrics: PDF 1406 views | HTML 289 views | ?
Xiaowei Zhang1,4,*, Ruixi Hua2,*, Xiaofeng Wang1,4, Mingzhu Huang1,4, Lu Gan1,4, Zhenhua Wu1,4, Jiejun Zhang1,4, Hongqiang Wang3, Yufan Cheng1,4, Jin Li1,4, Weijian Guo1,4
1Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
2Department of Medical Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
3Department of Cancer Chemotherapy Center, Zhoushan Hospital, Zhejiang, China
4Department of Oncology, Shanghai Medical College, Fudan University, Cancer Hospital of Fudan University, Shanghai, China
*These authors have contributed equally to this work
Weijian Guo, e-mail: firstname.lastname@example.org
Keywords: cancer stem cell, gastric cancer, stem cell marker, CD44, CD133
Received: June 07, 2015 Accepted: December 29, 2015 Published: January 12, 2016
The existence of gastric cancer stem cells (CSCs) has not been definitively proven and specific cell surface markers for identifying gastric CSCs have largely not been identified. Our research aimed to isolate potential gastric CSCs and clarify their clinical significance, while defining markers for GCSC identification and verification. Here, we report that spheroid cells possess stem cell-like properties, and overexpress certain stem cell markers. CD133 or CD44-positive cells also exhibit properties of CSCs. The expression of Oct4, Sox2, Gli1, CD44, CD133, p-AKT, and p-ERK was significantly higher in metastatic lesions compared to that in primary lesions. Elevated expression of some of these proteins was correlated with a more aggressive phenotype and poorer prognosis, including Oct4, Sox2, Gli1, CD44, and p-ERK. Multivariate Cox proportional hazards model analysis showed that only CD44 is an independent factor. Knockdown of CD44 down-regulated the stem cell-like properties, which was accompanied by the down-regulation of p-ERK and Oct4. Oct4 overexpression could reverse the decreased CSCs properties induced by CD44 knockdown. Taken together, our research revealed that spheroid cell culture, and CD133 or CD44-labeled FACS methods can be used to isolate gastric CSCs. Some CSC markers have clinical significance in predicting the prognosis. CD44 is an independent prognostic factor and maintains the properties of CSCs in CD44-p-ERK-Oct4 positive feedback loop.
Primary Contact _
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.